BioNTech SE (BNTX) Income Statement: Revenue & Earnings

BioNTech SE Income Statement Analysis

Revenue, earnings, and profit margins in billions EUR

Scale:

Scroll to see more

BioNTech SE income statement - Annual data in billions EUR
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	2.75	3.82	17.31	18.98	0.48
Cost of Revenue	0.54	0.60	3.00	2.91	0.06
Gross Profit	2.21	3.22	14.32	16.07	0.42
Operating Expenses
Research & Development	2.25	1.78	1.56	0.95	0.65
Selling, General & Administrative	0.60	0.56	-0.54	-0.33	0.11
Operating Expenses	3.52	2.53	2.01	-0.20	0.74
Operating Income	-1.31	0.69	12.30	14.92	-0.32
Other Income/Expense
Interest Income	0.00	0.36	0.05	0.00	0.00
Interest Expense	0.01	0.01	0.02	0.01	0.00
Other Income/Expense	0.64	-0.07	0.62	-0.16	-0.02
Income
Income Before Tax	-0.68	1.19	12.95	15.05	-0.15
Income Tax Expense	-0.01	0.26	3.52	4.75	-0.16
Net Income	-0.67	0.93	9.43	10.29	0.02
Net Income - Continuous Operations	-0.67	0.93	9.43	10.29	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-0.37	1.39	12.43	15.00	-0.29
EBIT	-0.65	1.21	12.30	14.93	-0.32
Depreciation & Amortization	0.30	0.18	-0.06	-0.01	0.03
Earnings Per Share
Basic EPS	-3.00	4.00	39.00	42.00	-
Diluted EPS	-3.00	4.00	38.00	40.00	-
Basic Shares Outstanding	0.24	0.24	0.24	0.24	0.24
Diluted Shares Outstanding	0.24	0.24	0.24	0.24	0.25